Logo image of EH

EHANG HOLDINGS LTD-SPS ADR (EH) Stock Fundamental Analysis

NASDAQ:EH - Nasdaq - US26853E1029 - ADR - Currency: USD

16.99  -0.24 (-1.39%)

Premarket: 17.09 +0.1 (+0.59%)

Fundamental Rating

5

Taking everything into account, EH scores 5 out of 10 in our fundamental rating. EH was compared to 65 industry peers in the Aerospace & Defense industry. While EH has a great health rating, there are worries on its profitability. EH shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EH had positive earnings in the past year.
EH had a positive operating cash flow in the past year.
In the past 5 years EH always reported negative net income.
In the past 5 years EH reported 4 times negative operating cash flow.
EH Yearly Net Income VS EBIT VS OCF VS FCFEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

EH's Return On Assets of -14.54% is on the low side compared to the rest of the industry. EH is outperformed by 72.31% of its industry peers.
EH has a worse Return On Equity (-24.09%) than 67.69% of its industry peers.
Industry RankSector Rank
ROA -14.54%
ROE -24.09%
ROIC N/A
ROA(3y)-42.25%
ROA(5y)-40.69%
ROE(3y)-143.11%
ROE(5y)-111.08%
ROIC(3y)N/A
ROIC(5y)N/A
EH Yearly ROA, ROE, ROICEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

EH has a better Gross Margin (61.26%) than 95.38% of its industry peers.
In the last couple of years the Gross Margin of EH has remained more or less at the same level.
EH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y0.99%
EH Yearly Profit, Operating, Gross MarginsEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

8

2. Health

2.1 Basic Checks

EH does not have a ROIC to compare to the WACC, probably because it is not profitable.
EH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EH has more shares outstanding
The debt/assets ratio for EH has been reduced compared to a year ago.
EH Yearly Shares OutstandingEH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EH Yearly Total Debt VS Total AssetsEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

EH has an Altman-Z score of 7.05. This indicates that EH is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 7.05, EH is doing good in the industry, outperforming 76.92% of the companies in the same industry.
The Debt to FCF ratio of EH is 0.81, which is an excellent value as it means it would take EH, only 0.81 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.81, EH belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
EH has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
EH's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. EH outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.81
Altman-Z 7.05
ROIC/WACCN/A
WACC8.65%
EH Yearly LT Debt VS Equity VS FCFEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.89 indicates that EH has no problem at all paying its short term obligations.
The Current ratio of EH (2.89) is better than 64.62% of its industry peers.
EH has a Quick Ratio of 2.73. This indicates that EH is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EH (2.73) is better than 83.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 2.73
EH Yearly Current Assets VS Current LiabilitesEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

EH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.05%, which is quite impressive.
EH shows a strong growth in Revenue. In the last year, the Revenue has grown by 288.33%.
Measured over the past years, EH shows a very strong growth in Revenue. The Revenue has been growing by 30.21% on average per year.
EPS 1Y (TTM)31.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2000%
Revenue 1Y (TTM)288.33%
Revenue growth 3Y100.23%
Revenue growth 5Y30.21%
Sales Q2Q%205.21%

3.2 Future

Based on estimates for the next years, EH will show a very strong growth in Earnings Per Share. The EPS will grow by 71.43% on average per year.
EH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.73% yearly.
EPS Next Y-313.81%
EPS Next 2Y45.51%
EPS Next 3Y84.85%
EPS Next 5Y71.43%
Revenue Next Year107.76%
Revenue Next 2Y82.13%
Revenue Next 3Y67.97%
Revenue Next 5Y49.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EH Yearly Revenue VS EstimatesEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
EH Yearly EPS VS EstimatesEH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 424.75, which means the current valuation is very expensive for EH.
64.62% of the companies in the same industry are cheaper than EH, based on the Price/Earnings ratio.
EH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.98.
With a Price/Forward Earnings ratio of 80.53, EH can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, EH is valued a bit more expensive than the industry average as 63.08% of the companies are valued more cheaply.
EH is valuated expensively when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 424.75
Fwd PE 80.53
EH Price Earnings VS Forward Price EarningsEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as EH.
Industry RankSector Rank
P/FCF 74.33
EV/EBITDA N/A
EH Per share dataEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

EH's earnings are expected to grow with 84.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.51%
EPS Next 3Y84.85%

0

5. Dividend

5.1 Amount

EH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EHANG HOLDINGS LTD-SPS ADR

NASDAQ:EH (6/27/2025, 8:03:51 PM)

Premarket: 17.09 +0.1 (+0.59%)

16.99

-0.24 (-1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-26 2025-05-26/bmo
Earnings (Next)08-20 2025-08-20
Inst Owners33.03%
Inst Owner Change13.59%
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap1.22B
Analysts86
Price Target26.78 (57.62%)
Short Float %21.29%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.81%
Min EPS beat(2)126.03%
Max EPS beat(2)195.58%
EPS beat(4)4
Avg EPS beat(4)125.28%
Min EPS beat(4)77.82%
Max EPS beat(4)195.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.78%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)9.46%
Revenue beat(4)3
Avg Revenue beat(4)7.7%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)20.82%
Revenue beat(8)6
Avg Revenue beat(8)58.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.13%
PT rev (3m)1.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-622.78%
EPS NY rev (1m)-590.36%
EPS NY rev (3m)-1212.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)602.59%
Revenue NY rev (1m)-3.76%
Revenue NY rev (3m)639.82%
Valuation
Industry RankSector Rank
PE 424.75
Fwd PE 80.53
P/S 19.25
P/FCF 74.33
P/OCF 55.51
P/B 9.18
P/tB 9.21
EV/EBITDA N/A
EPS(TTM)0.04
EY0.24%
EPS(NY)0.21
Fwd EY1.24%
FCF(TTM)0.23
FCFY1.35%
OCF(TTM)0.31
OCFY1.8%
SpS0.88
BVpS1.85
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -24.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.26%
FCFM 25.89%
ROA(3y)-42.25%
ROA(5y)-40.69%
ROE(3y)-143.11%
ROE(5y)-111.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y0.99%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.81
Debt/EBITDA N/A
Cap/Depr 307.69%
Cap/Sales 8.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 2.73
Altman-Z 7.05
F-Score6
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)177.12%
Cap/Depr(5y)175.98%
Cap/Sales(3y)15.9%
Cap/Sales(5y)16.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2000%
EPS Next Y-313.81%
EPS Next 2Y45.51%
EPS Next 3Y84.85%
EPS Next 5Y71.43%
Revenue 1Y (TTM)288.33%
Revenue growth 3Y100.23%
Revenue growth 5Y30.21%
Sales Q2Q%205.21%
Revenue Next Year107.76%
Revenue Next 2Y82.13%
Revenue Next 3Y67.97%
Revenue Next 5Y49.73%
EBIT growth 1Y14.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.44%
EBIT Next 3Y56.26%
EBIT Next 5YN/A
FCF growth 1Y221.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y278.71%
OCF growth 3YN/A
OCF growth 5YN/A